This Week’s Focus: NDEWS Early Warning in Action — Insights from the NDEWS Early Warning Network including Sentinel Sites Report and Rapid Street Reporting data This week, the NDEWS Weekly Briefing focuses on our Sentinel Site Director (SSD) report and our newest Rapid Street Reporting (RSR) findings from our…
This Week’s Focus: Psilocybin This week’s briefing focuses on psilocybin, a chemical in certain types of fresh or dried mushrooms, also known as shrooms or magic mushrooms. The mushrooms cause behavioral changes and changes in how a person perceives reality; they may see colors, shapes, or scenes that aren’t…
This Week’s Focus: Ketamine Our focus for this week’s NDEWS Weekly Briefing is on the trends of non-medical use, detection, and the risks associated with overdoses involving ketamine.We feature our latest NDEWS Special Report that focuses on EMS encounters for nonfatal ketamine-related overdoses in the US, in…
Article published in TIME, features insight from NDEWS Co-Director Joseph Palamar and SAG member Alex Krotulski, exploring the rise of nitazenes. The article describes nitazenes, discusses emerging trends, and explains the challenges with detection of the substance.
NDEWS Deputy Director, Dr. Joseph Palamar, presented along with Dr. Joshua DeBord of the Center for Forensic Science Research and Education (CFSRE) on monitoring of drug trends in the US, during the Trends, Analysis, & Threats webinar, hosted by the Overdose Response Strategy (ORS) Program.
NIDA T32 Predoctoral trainee Vijaya L. Seegulam graduated Friday, August 8, with her PhD in Epidemiology from the University of Florida. Additionally, in July, NDEWS MPI Dr. Joseph Palamar was promoted to Professor of Population Health at NYU Langone Health. Congratulations to Drs. Seegulam and Palamar.
7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat report by the FDA highlights the work of NDEWS' Web Monitoring team.
Following the NDEWS 4th Annual Summit, members of the NDEWS Coordinating Center (CC) will present a late-breaking abstract, an oral presentation, symposiums, and posters showcasing our latest data while at CPDD. In addition to presenting at CPDD, NDEWS Director, Dr. Linda Cottler (MPI), will deliver the keynote during the 2025 CPDD/RSA Joint Program focusing on NDEWS.
Teen nonmedical misuse of medications may be more common than we believed. In Psychology Today’s Addiction Outlook column, Dr. Mark Gold discusses that teen nonmedical misuse of medications like dextromethorphan (DXM) and promethazine may be more widespread than previously recognized. Dr. Linda B. Cottler, Director of NDEWS,…
Jim Hall is a retired epidemiologist who worked for 35 years at Nova Southeastern University in Davie, Florida, and since 1982 has served as director of the Up Front Drug Information Center in Miami. From 1984 to 2014, he served as the Florida representative to the NIDA Community Epidemiology Work Group (CEWG), the predecessor to NDEWS. Through Nova Southeastern University, Hall more recently served as a consultant with the United Way of Broward County’s Commission on Behavioral Health and Drug Prevention, formerly the Commission on Substance Abuse, which was one of the earliest drug-free community programs that is part of the Community Anti-Drug Coalitions of America (CADCA).
